Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick J Hayden

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Clinical Case Reports|January 2, 2020
Sorafenib for relapsed <i>FLT3</i>-ITD-positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutisRachel Brodie, Stephen E Langabeer, John Quinn, et al.
Leukemia & Lymphoma|August 31, 2013
Symptomatic BK virus reactivation following fludarabine, cyclophosphamide and rituximab chemotherapy for chronic lymphocytic leukemia/small lymphocytic lymphomaNiamh Appleby, Anna Dillon, Martin Arrigan, et al.
Leukemia Research|January 7, 2019
Molecular response to imatinib in KIT F522C-mutated systemic mastocytosisValerie Broderick, Katherine Waghorn, Stephen E Langabeer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2020
Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMTLaurent Garderet, Curly Morris, Meral Beksac, et al.
Haematologica|March 15, 2006
The value of autofluorescence as a diagnostic feature of acute promyelocytic leukemiaPatrick J Hayden, Niamh M O'Connell, David A O'Brien, et al.
The Journal of Pharmacy and Pharmacology|November 30, 2006
Permeation of WIN 55,212-2, a potent cannabinoid receptor agonist, across human tracheo-bronchial tissue in vitro and rat nasal epithelium in vivoRemigius U Agu, Satyanarayana Valiveti, Kalpana S Paudel, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 6, 2023
Evaluation of in vitro rat and human airway epithelial models for acute inhalation toxicity testingJoanne Wallace, George R Jackson, Yulia Kaluzhny, et al.
Annals of Hematology|January 24, 2018
The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myelomaIris Breitkreutz, Klaus Podar, Vianihuini Figueroa-Vazquez, et al.
Leukemia & Lymphoma|February 23, 2011
A novel e8a2 BCR-ABL1 fusion with insertion of RALGPS1 exon 8 in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemiaSarah L McCarron, Johanna Kelly, Natasha Coen, et al.
Endocrine Research|November 24, 2004
Intranasal delivery of recombinant human parathyroid hormone [hPTH (1-34)], teriparatide in ratsRemigius U Agu, Satyanarayana Valiveti, D Caroline Earles, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Clinical Case Reports|January 2, 2020
Sorafenib for relapsed <i>FLT3</i>-ITD-positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutisRachel Brodie, Stephen E Langabeer, John Quinn, et al.
Leukemia & Lymphoma|August 31, 2013
Symptomatic BK virus reactivation following fludarabine, cyclophosphamide and rituximab chemotherapy for chronic lymphocytic leukemia/small lymphocytic lymphomaNiamh Appleby, Anna Dillon, Martin Arrigan, et al.
Leukemia Research|January 7, 2019
Molecular response to imatinib in KIT F522C-mutated systemic mastocytosisValerie Broderick, Katherine Waghorn, Stephen E Langabeer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2020
Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMTLaurent Garderet, Curly Morris, Meral Beksac, et al.
Haematologica|March 15, 2006
The value of autofluorescence as a diagnostic feature of acute promyelocytic leukemiaPatrick J Hayden, Niamh M O'Connell, David A O'Brien, et al.
The Journal of Pharmacy and Pharmacology|November 30, 2006
Permeation of WIN 55,212-2, a potent cannabinoid receptor agonist, across human tracheo-bronchial tissue in vitro and rat nasal epithelium in vivoRemigius U Agu, Satyanarayana Valiveti, Kalpana S Paudel, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 6, 2023
Evaluation of in vitro rat and human airway epithelial models for acute inhalation toxicity testingJoanne Wallace, George R Jackson, Yulia Kaluzhny, et al.
Annals of Hematology|January 24, 2018
The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myelomaIris Breitkreutz, Klaus Podar, Vianihuini Figueroa-Vazquez, et al.
Leukemia & Lymphoma|February 23, 2011
A novel e8a2 BCR-ABL1 fusion with insertion of RALGPS1 exon 8 in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemiaSarah L McCarron, Johanna Kelly, Natasha Coen, et al.
Endocrine Research|November 24, 2004
Intranasal delivery of recombinant human parathyroid hormone [hPTH (1-34)], teriparatide in ratsRemigius U Agu, Satyanarayana Valiveti, D Caroline Earles, et al.
Pageof 8